Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Kill or corrupt: Mechanisms of action and drug-resistance of nucleotide analogues against SARS-CoV-2
Ashleigh Shannon, Bruno Canard
Antiviral Research (2022) Vol. 210, pp. 105501-105501
Open Access | Times Cited: 24

Showing 24 citing articles:

Small Molecule Drugs Targeting Viral Polymerases
Deborah Palazzotti, Martina Sguilla, Giuseppe Manfroni, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 661-661
Open Access | Times Cited: 7
Recent Advances in Molecular Mechanisms of Nucleoside Antivirals
Polina N. Kamzeeva, Andrey V. Aralov, Vera A. Alferova, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 8, pp. 6851-6879
Open Access | Times Cited: 15
Synergism between remdesivir and ribavirin leads to SARS‐CoV‐2 extinction in cell culture
Carlos García‐Crespo, Ana Isabel de Ávila, Isabel Gallego, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 15, pp. 2636-2654
Open Access | Times Cited: 6
Effectiveness of nucleoside analogs against Wetland virus infection
Rui Wang, Xi Wang, Jianzhong Zhu, et al.
Antiviral Research (2025), pp. 106114-106114
Closed Access
Structure-Based Drug Design of RdRp Inhibitors against SARS-CoV-2
Kiran Shehzadi, Afsheen Saba, Mingjia Yu, et al.
Topics in Current Chemistry (2023) Vol. 381, Iss. 5
Closed Access | Times Cited: 11
Transient SARS-CoV-2 RNA-Dependent RNA Polymerase Mutations after Remdesivir Treatment for Chronic COVID-19 in Two Transplant Recipients: Case Report and Intra-Host Viral Genomic Investigation
Shangxin Yang, Ashrit Multani, Jacob M. Garrigues, et al.
Microorganisms (2023) Vol. 11, Iss. 8, pp. 2096-2096
Open Access | Times Cited: 8
Antiviral therapies for the management of persistent coronavirus disease 2019 in immunocompromised hosts: A narrative review
Paul Kinsella, Michael A. Moso, C. Orla Morrissey, et al.
Transplant Infectious Disease (2024) Vol. 26, Iss. 3
Open Access | Times Cited: 2
Elucidating the Role of Noncovalent Interactions in Favipiravir, a Drug Active against Various Human RNA Viruses; a 1H-14N NQDR/Periodic DFT/QTAIM/RDS/3D Hirshfeld Surfaces Combined Study
Jolanta Natalia Latosińska, Magdalena Latosińska, J. Seliger, et al.
Molecules (2023) Vol. 28, Iss. 8, pp. 3308-3308
Open Access | Times Cited: 7
Synthesis and anti-SARS-CoV-2 evaluation of lipid prodrugs of β-D-N4-hydroxycytidine (NHC) and a 3′-fluoro-substituted analogue of NHC
Zhaohui Wen, Mengmeng Wang, Lingyun Li, et al.
Bioorganic Chemistry (2023) Vol. 135, pp. 106527-106527
Open Access | Times Cited: 5
In vitro testing of host-targeting small molecule antiviral matriptase/TMPRSS2 inhibitors in 2D and 3D cell-based assays
Nicholas van Eijk, Luna C. Schmacke, Torsten Steinmetzer, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115761-115761
Open Access | Times Cited: 5
The activation cascade of the broad-spectrum antiviral bemnifosbuvir characterized at atomic resolution
Aurélie Chazot, Claire Zimberger, Mikaël Feracci, et al.
PLoS Biology (2024) Vol. 22, Iss. 8, pp. e3002743-e3002743
Open Access | Times Cited: 1
Ultrasound-assisted preparation of zein particles: Insight into the effects and mechanisms of thermal factors
Wujun You, Hongge Liu, Benjamin Ndeshipanda Kashenye, et al.
Innovative Food Science & Emerging Technologies (2024), pp. 103825-103825
Closed Access | Times Cited: 1
An exonuclease-resistant chain-terminating nucleotide analogue targeting the SARS-CoV-2 replicase complex
Ashleigh Shannon, Aurélie Chazot, Mikaël Feracci, et al.
Nucleic Acids Research (2023) Vol. 52, Iss. 3, pp. 1325-1340
Open Access | Times Cited: 3
Structural and Synthetic Aspects of Small Ring Oxa- and Aza-Heterocyclic Ring Systems as Antiviral Activities
Sibasish Manna, Koushik K. Das, Sougata Santra, et al.
Viruses (2023) Vol. 15, Iss. 9, pp. 1826-1826
Open Access | Times Cited: 2
The activation chain of the broad-spectrum antiviral bemnifosbuvir at atomic resolution
Aurélie Chazot, Claire Zimberger, Mikaël Feracci, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
New insights into complex formation by SARS-CoV-2 nsp10 and nsp14
Céleste Sèle, Ewa Krupinska, Anna Andersson Rasmussen, et al.
Nucleosides Nucleotides & Nucleic Acids (2024) Vol. 43, Iss. 8, pp. 798-812
Open Access
Effectiveness of recently-approved oral antiviral medications on the outcome of patients with mild-to-moderate COVID-19 and pre–existing chronic obstructive pulmonary diseases
Bo-Wen Shiau, Wan‐Hsuan Hsu, Ya‐Wen Tsai, et al.
Expert Review of Anti-infective Therapy (2024) Vol. 22, Iss. 11, pp. 977-985
Closed Access
Exploring nucleoside analogs: key targets in the viral life cycle - advancing strategies against SARS-CoV-2
Roopal Garg, Raveen Kumar, Ritika Srivastava, et al.
Medicinal Chemistry Research (2024) Vol. 33, Iss. 6, pp. 869-884
Closed Access
The Impact of SARS-CoV-2 nsp14 Proofreading on Nucleoside Antiviral Activity: Insights from Genetic and Pharmacological Investigations
Ju-Yi Peng, Frederick Lahser, Christopher Warren, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
The effects of Remdesivir’s functional groups on its antiviral potency and resistance against the SARS-CoV-2 polymerase
Bhawna Sama, Barbara Selisko, Camille Falcou, et al.
Antiviral Research (2024) Vol. 232, pp. 106034-106034
Open Access
Oligomeric State of β-Coronavirus Non-Structural Protein 10 Stimulators Studied by Small Angle X-ray Scattering
Wolfgang Knecht, S. Zoë Fisher, Jiaqi Lou, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13649-13649
Open Access | Times Cited: 1
Synthesis and Antiviral Activity of Novel β-D-N4-Hydroxycytidine Ester Prodrugs as Potential Compounds for the Treatment of SARS-CoV-2 and Other Human Coronaviruses
E.S. Darnotuk, Andrei E. Siniavin, Natal’ya S. Shastina, et al.
Pharmaceuticals (2023) Vol. 17, Iss. 1, pp. 35-35
Open Access | Times Cited: 1
Oligomeric state of β-coronavirus non-structural protein 10 stimulators studied by OmniSEC and Small Angle X-ray Scattering
Wolfgang Knecht, S. Zoë Fisher, Jiaqi Lou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Development and Validation of In-vitro Release Study of Molnupiravir Capsules by RP-HPLC
Shipra Singhal, Aman Sharma, Anirudh Malik, et al.
Current Pharmaceutical Analysis (2023) Vol. 19, Iss. 7, pp. 577-585
Closed Access
Page 1

Scroll to top